Sangamo Therapeutics所有資訊

Sangamo Therapeutics | 8-K：重大事件

04/30 16:57 (美東)

Sangamo Therapeutics | ARS：年度報告

04/19 16:20 (美東)

Sangamo Therapeutics | DEF 14A：股東委託書決議

04/19 16:06 (美東)

Sangamo Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)

04/05 16:04 (美東)

Sangamo Therapeutics | PRE 14A：並購重組委托聲明

04/03 17:21 (美東)

Sangamo Therapeutics | 8-K：重大事件

03/25 17:09 (美東)

Sangamo Therapeutics | 424B5：募資說明書

03/25 16:06 (美東)

Sangamo Therapeutics | 8-K：SANGAMO THERAPEUTICS公佈了最近的業務亮點以及2023年第四季度和全年財務業績

03/13 07:58 (美東)

Sangamo Therapeutics | 10-K：年度報表

03/13 07:53 (美東)

Sangamo Therapeutics | 4：持股變動聲明-高管 Duraibabu Prathyusha

02/27 17:18 (美東)

Sangamo Therapeutics | 4：持股變動聲明-高管 Dubois-Stringfellow Nathalie

02/27 17:18 (美東)

Sangamo Therapeutics | 4：持股變動聲明-高管 Willoughby Scott B.

02/27 17:17 (美東)

Sangamo Therapeutics | 4：持股變動聲明-高管 Pooler Amy

02/27 17:17 (美東)

Sangamo Therapeutics | 4：持股變動聲明-高管 Macrae Sandy

02/27 17:17 (美東)

Sangamo Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-The Vanguard Group(7.10%)

02/13 22:36 (美東)

Sangamo Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Biogen Inc.(8.26%),Biogen MA Inc.(8.26%)

02/12 19:15 (美東)

Sangamo Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)

02/09 12:20 (美東)

Sangamo Therapeutics | 8-K：重大事件

02/06 16:39 (美東)

Sangamo Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-BlackRock, Inc.(7.9%)

01/26 11:54 (美東)

Sangamo Therapeutics | 4：持股變動聲明-高管 Pooler Amy

01/24 16:46 (美東)